Mark Hamner to Remission Induction
This is a "connection" page, showing publications Mark Hamner has written about Remission Induction.
Connection Strength
0.093
-
Effect of Pharmacogenomic Testing for Drug-Gene Interactions on Medication Selection and Remission of Symptoms in Major Depressive Disorder: The PRIME Care Randomized Clinical Trial. JAMA. 2022 07 12; 328(2):151-161.
Score: 0.050
-
Cortisol awakening response in PTSD treatment: Predictor or mechanism of change. Psychoneuroendocrinology. 2020 08; 118:104714.
Score: 0.043